Brief: Orchid Pharma Says To Transfer NPNC Formulations Division To JV With Bionpharma Unit
06/05/2021 11:00
May 6 (Reuters) - Orchid Pharma Ltd ORCD.NS :
* ORCHID PHARMA - TO TRANSFER NPNC FORMULATIONS DIVISION (IKKT UNDERTAKING) TO JV WITH
BIONPHARMA
UNIT
* ORCHID PHARMA - CONSIDERATION FOR TRANSACTION IS ESTIMATED TO BE UP TO 1.70 BILLION RUPEES
Source text - https://bit.ly/3elpPYD
Further company coverage: ORCD.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orchid Pharma
See all newsBrief: Orchid Pharma Approves Enabling Resolution To Explore Fund Raising Via Equity Or Other Securities
Brief: Orchid Pharma To Consider And Evaluate Various Options For Raising Funds
Brief: Orchid Pharma June-Quarter Consol Profit 25.8 Million Rupees
India's Orchid Pharma jumps on pact to commercialize Exblifep in Russia
Refile: INDIA STOCKS-Indian shares set to open lower as US-Iran tensions lift oil prices